Current Edition

Is there a Future for Medical/Diagnostic Patents in the US?

A fair number of diagnostic and pharmaceutical companies remain perplexed by the recent decision in the ‘Mayo vs Prometheus’ US Supreme Court case. Sara Reekmans at LC Patents explains why, depending on the interpretation of the decision, thousands of existing patents could be challenged.